The bile diversion device developed by Endobetix is featured in this report on obesity from CANACCORD Genuity.
Welcome to Trendlines
We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >
Subscribe to Our Newsletter
Stay in Touch